225 related articles for article (PubMed ID: 18829532)
21. Opposing roles of p190RhoGAP and Ect2 RhoGEF in regulating cytokinesis.
Mikawa M; Su L; Parsons SJ
Cell Cycle; 2008 Jul; 7(13):2003-12. PubMed ID: 18642445
[TBL] [Abstract][Full Text] [Related]
22. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
23. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
Lukong KE; Richard S
Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
[TBL] [Abstract][Full Text] [Related]
24. Identification of STAT3 as a specific substrate of breast tumor kinase.
Liu L; Gao Y; Qiu H; Miller WT; Poli V; Reich NC
Oncogene; 2006 Aug; 25(35):4904-12. PubMed ID: 16568091
[TBL] [Abstract][Full Text] [Related]
25. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
[TBL] [Abstract][Full Text] [Related]
26. Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.
Cheng JC; Frackelton AR; Bearer EL; Kumar PS; Kannan B; Santos-Moore A; Rifai A; Settleman J; Clark JW
Cell Growth Differ; 1995 Feb; 6(2):139-48. PubMed ID: 7756172
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.
van der Geer P; Henkemeyer M; Jacks T; Pawson T
Mol Cell Biol; 1997 Apr; 17(4):1840-7. PubMed ID: 9121432
[TBL] [Abstract][Full Text] [Related]
28. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation.
Harvey AJ; Crompton MR
Oncogene; 2003 Aug; 22(32):5006-10. PubMed ID: 12902983
[TBL] [Abstract][Full Text] [Related]
29. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
[TBL] [Abstract][Full Text] [Related]
30. The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.
Naoe H; Araki K; Nagano O; Kobayashi Y; Ishizawa J; Chiyoda T; Shimizu T; Yamamura K; Sasaki Y; Saya H; Kuninaka S
Mol Cell Biol; 2010 Aug; 30(16):3994-4005. PubMed ID: 20530197
[TBL] [Abstract][Full Text] [Related]
31. p190-RhoGAP as an integral component of the Tiam1/Rac1-induced downregulation of Rho.
Herbrand U; Ahmadian MR
Biol Chem; 2006 Mar; 387(3):311-7. PubMed ID: 16542153
[TBL] [Abstract][Full Text] [Related]
32. Two SH2 domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein.
Bryant SS; Briggs S; Smithgall TE; Martin GA; McCormick F; Chang JH; Parsons SJ; Jove R
J Biol Chem; 1995 Jul; 270(30):17947-52. PubMed ID: 7629101
[TBL] [Abstract][Full Text] [Related]
33. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
34. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway.
Kontaridis MI; Eminaga S; Fornaro M; Zito CI; Sordella R; Settleman J; Bennett AM
Mol Cell Biol; 2004 Jun; 24(12):5340-52. PubMed ID: 15169898
[TBL] [Abstract][Full Text] [Related]
35. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
[TBL] [Abstract][Full Text] [Related]
36. The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function.
Todorovic B; Nichols AC; Chitilian JM; Myers MP; Shepherd TG; Parsons SJ; Barrett JW; Banks L; Mymryk JS
J Virol; 2014 Apr; 88(7):3653-63. PubMed ID: 24403595
[TBL] [Abstract][Full Text] [Related]
37. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
Brunton VG; Ozanne BW; Paraskeva C; Frame MC
Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
[TBL] [Abstract][Full Text] [Related]
38. Adhesion-dependent regulation of p190RhoGAP in the developing brain by the Abl-related gene tyrosine kinase.
Hernández SE; Settleman J; Koleske AJ
Curr Biol; 2004 Apr; 14(8):691-6. PubMed ID: 15084284
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone.
Shiota M; Tanihiro T; Nakagawa Y; Aoki N; Ishida N; Miyazaki K; Ullrich A; Miyazaki H
Mol Endocrinol; 2003 Apr; 17(4):534-49. PubMed ID: 12554790
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.
Chang JH; Wilson LK; Moyers JS; Zhang K; Parsons SJ
Oncogene; 1993 Apr; 8(4):959-67. PubMed ID: 7681161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
